Integrated Pharma Services
Integrated Pharma Services (IPS) is a woman-owned, award-winning research organization based in Rockville, Maryland, specializing in pre-clinical and clinical research, including development and evaluation of antimicrobials and medical devices. They focus on high-quality scientific data and insights to support product development and regulatory approval, serving clients from startups to large corporations. IPS has state-of-the-art laboratories, a strong scientific reputation, and a commitment to innovation in therapeutics, diagnostics, and medical device testing.
Industries
Nr. of Employees
small (1-50)
Integrated Pharma Services
4 Research Court, Suite 100, Rockville, MD 20850
Products
High-throughput biofilm testing platform (development)
Platform and standardized methods for parallel measurement of biofilm biomass and antimicrobial susceptibility across large isolate panels.
Microbiome-based topical therapeutics (pipeline)
Development of microbiome-derived topical formulations intended for infection control and women's health indications.
Phage-based therapeutics (pipeline)
Isolation and development of bacteriophage candidates for therapeutic application against specific bacterial pathogens and biofilms.
Antifungal and wound-care therapeutic development (pipeline)
Research and early development of antifungal candidates (including agents targeting drug-resistant species) and regenerative wound-care technologies such as next-generation skin graft platforms.
High-throughput biofilm testing platform (development)
Platform and standardized methods for parallel measurement of biofilm biomass and antimicrobial susceptibility across large isolate panels.
Microbiome-based topical therapeutics (pipeline)
Development of microbiome-derived topical formulations intended for infection control and women's health indications.
Phage-based therapeutics (pipeline)
Isolation and development of bacteriophage candidates for therapeutic application against specific bacterial pathogens and biofilms.
Antifungal and wound-care therapeutic development (pipeline)
Research and early development of antifungal candidates (including agents targeting drug-resistant species) and regenerative wound-care technologies such as next-generation skin graft platforms.
Services
Customizable preclinical studies for therapeutics and devices using a broad biorepository of pathogens; supports large-scale and tailored study designs.
Testing against an extensive documented panel of bacterial, fungal and parasitic organisms with multi-strain coverage for efficacy, susceptibility and diagnostic performance studies.
Expedited antiviral testing of textiles, plastics and glass surfaces using ISO and ASTM-aligned methods for material and product evaluation.
Study design, operational support, data review and preparation of clinical documentation for regulatory filings and inspections.
Broad microbiological and analytical assay portfolio including antiviral, antimicrobial, viral neutralization, biomarker, endotoxin, bioburden and electrophoresis testing with GLP and non-GLP execution.
Independent validation of assays, instruments and diagnostic devices to produce third-party performance reports suitable for regulatory submissions.
Customizable preclinical studies for therapeutics and devices using a broad biorepository of pathogens; supports large-scale and tailored study designs.
Testing against an extensive documented panel of bacterial, fungal and parasitic organisms with multi-strain coverage for efficacy, susceptibility and diagnostic performance studies.
Expedited antiviral testing of textiles, plastics and glass surfaces using ISO and ASTM-aligned methods for material and product evaluation.
Study design, operational support, data review and preparation of clinical documentation for regulatory filings and inspections.
Broad microbiological and analytical assay portfolio including antiviral, antimicrobial, viral neutralization, biomarker, endotoxin, bioburden and electrophoresis testing with GLP and non-GLP execution.
Independent validation of assays, instruments and diagnostic devices to produce third-party performance reports suitable for regulatory submissions.
Expertise Areas
- Preclinical infectious disease research and testing
- Antimicrobial and antiviral efficacy testing
- Biofilm screening and anti-biofilm evaluation
- Assay development, optimization and analytical validation
Key Technologies
- High-throughput biofilm testing platforms
- Viral neutralization assays
- Immunoassay optimization and validation
- Tissue culture and in vitro skin models
News & Updates
Celebration of pilots and recognition of women pilots.
Participation in the Maryland Asian American Business Conference.
Participation in the Maryland MedTech Summit at the University of Maryland.
Introduction of new intern Abdelmoneim Abdelmoneim.
Celebration and recognition of women employees and leaders.
Award for development of novel therapeutics for Candida auris.
Celebration of pilots and recognition of women pilots.
Participation in the Maryland Asian American Business Conference.
Participation in the Maryland MedTech Summit at the University of Maryland.
Introduction of new intern Abdelmoneim Abdelmoneim.
Celebration and recognition of women employees and leaders.
Award for development of novel therapeutics for Candida auris.